Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOS2 | P35228 | 8/20 | 0.44 |
| ▸ | NOS1 | P29475 | 7/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | NOS3 | P29474 | 4/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | SCN2A | Q99250 | 2/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29117666 | 0.98 | ALDH1A1 (0.44) | NOS2NOS1ALDH1A1NOS3CYP1A2 | |
| SCHEMBL10339612 | 0.98 | ALDH1A1 (0.44) | NOS2NOS1ALDH1A1NOS3CYP1A2 | |
| SCHEMBL1726234 | 0.79 | TAAR1 (0.57) | NOS2NOS1TAAR1 | |
| SCHEMBL8710340 | 0.78 | TAAR1 (0.55) | NOS2NOS1TAAR1 | |
| SCHEMBL7091189 | 0.78 | NOS2 (0.41) | NOS2NOS1ALDH1A1NOS3CYP1A2 | |
| SCHEMBL7854852 | 0.77 | ALDH1A1 (0.41) | NOS2NOS1ALDH1A1NOS3CYP1A2 | |
| SCHEMBL7857240 | 0.77 | ALDH1A1 (0.41) | NOS2NOS1ALDH1A1NOS3CYP1A2 | |
| SCHEMBL7651855 | 0.77 | ALDH1A1 (0.41) | NOS2NOS1ALDH1A1NOS3CYP1A2 | |
| SCHEMBL7846606 | 0.77 | ALDH1A1 (0.41) | NOS2NOS1ALDH1A1NOS3CYP1A2 | |
| SCHEMBL7856874 | 0.77 | ALDH1A1 (0.41) | NOS2NOS1ALDH1A1NOS3CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005017619-A1 | IMAGING MATERIAL WITH IMPROVED MECHANICAL PROPERTIES | EASTMAN KODAK COMPANY (US) | 2005-02-24 | — | — | WO | disclosed |